Literature DB >> 21947724

Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells.

Qing-Lan Wang1, Quoc Wu, Yan-Yan Tao, Cheng-Hai Liu, Hani El-Nezami.   

Abstract

BACKGROUND: Enzymes involved in drug and xenobiotic metabolism have been considered to exist in two groups: phase I and phase II enzymes. Cytochrome P450 isoenzymes (CYPs) are the most important phase I enzymes in the metabolism of xenobiotics. The products of phase I metabolism are then acted upon by phase II enzymes, including glutathione S-transferases (GSTs). Herbs that inhibit CYPs such as CYP3A4 or that induce GSTs may have the potential to protect against chemical carcinogenesis since the mutagenic effects of carcinogens are often mediated through an excess of CYP-generated reactive intermediates. This study was designed to investigate the effects of salvianolic acid B (Sal B), a pure compound extracted from Radix Salviae Miltiorrhizae, a Chinese herb, on cell proliferation and CYP1A2 and CYP3A4 mRNA expression in the presence or absence of rifampicin, a potent inducer of CYPs and GST protein expression in HepG2 cells.
METHODS: HepG2 cells were incubated with different concentrations of Sal B. Cell proliferation was determined by SYTOX-Green nucleic acid staining. CYP3A4 and CYP1A2 mRNA expression was assayed by real-time PCR. GST protein expression was analyzed by Western blotting.
RESULTS: Low concentrations of Sal B (0-20 μmol/L) had no significant effects on cell proliferation, while higher concentrations (100-250 μmol/L) significantly inhibited proliferation in a concentration-dependent manner. Ten μmol/L Sal B, but not 1 μmol/L, down-regulated CYP3A4 and CYP1A2 mRNA expression after 24 hours of incubation, whereas both 1 and 10 μmol/L Sal B down-regulated CYP3A4 mRNA expression after 96 hours of incubation; moreover, 1 and 10 μmol/L Sal B inhibited CYP3A4 mRNA expression induced by rifampicin. Both 1 μmol/L and 10 μmol/L Sal B increased GST expression.
CONCLUSION: Sal B inhibits CYP3A4 and CYP1A2 mRNA expression and induces GST expression in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947724     DOI: 10.1016/s1499-3872(11)60085-4

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  11 in total

1.  Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.

Authors:  Wenjing Luo; Yu Xin; Xia Zhao; Feng Zhang; Changqing Liu; Hongwei Fan; Tao Xi; Jing Xiong
Journal:  Br J Pharmacol       Date:  2017-03-03       Impact factor: 8.739

Review 2.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

3.  A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.

Authors:  Artitaya Thiengsusuk; Kanyarat Boonprasert; Kesara Na-Bangchang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

4.  Different Contribution of Redox-Sensitive Transient Receptor Potential Channels to Acetaminophen-Induced Death of Human Hepatoma Cell Line.

Authors:  Heba Badr; Daisuke Kozai; Reiko Sakaguchi; Tomohiro Numata; Yasuo Mori
Journal:  Front Pharmacol       Date:  2016-02-09       Impact factor: 5.810

Review 5.  Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions.

Authors:  Feng Chen; Li Li; Dan-Dan Tian
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

6.  Salvianolic acid B, a novel autophagy inducer, exerts antitumor activity as a single agent in colorectal cancer cells.

Authors:  Zhao Jing; Weiqiang Fei; Jichun Zhou; Lumin Zhang; Liuxi Chen; Xiaomin Zhang; Xiao Liang; Jiansheng Xie; Yong Fang; Xinbing Sui; Weidong Han; Hongming Pan
Journal:  Oncotarget       Date:  2016-09-20

Review 7.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

8.  QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats.

Authors:  Congyang Ding; Yajing Li; Xiao Li; Lu Meng; Ran Fu; Xiaonan Wang; Ying Li; Yinling Ma; Zhanjun Dong
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

9.  Salvianolic Acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro.

Authors:  Min Wang; Guibo Sun; Ping Wu; Rongchang Chen; Fan Yao; Meng Qin; Yun Luo; Hong Sun; Qiang Zhang; Xi Dong; Xiaobo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-08       Impact factor: 2.629

10.  Chemical Characterization and Bioactivity of Extracts from Thymus mastichina: A Thymus with a Distinct Salvianolic Acid Composition.

Authors:  Meriem Taghouti; Carlos Martins-Gomes; Judith Schäfer; João A Santos; Mirko Bunzel; Fernando M Nunes; Amélia M Silva
Journal:  Antioxidants (Basel)       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.